Stay updated on OASIS-HAE: Donidalorsen Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the OASIS-HAE: Donidalorsen Safety & Efficacy Clinical Trial page.

Latest updates to the OASIS-HAE: Donidalorsen Safety & Efficacy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange Detected- Footer revision label updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedNew revision entry v3.3.1 was added to the record history, and the v3.2.0 entry was removed. This update affects only the version history and does not change study content or results.SummaryDifference0.1%

- Check29 days agoChange DetectedThe new screenshot removes the government funding notice banner that appeared in the old page. The study record content and layout otherwise remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedAdded a new version entry dated 2025-02-13 to the record history indicating a Study Status update, while the rest of the page content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedMajor change: update to v3.2.0 and a prominent notice about funding-related accessibility and where to check operating status. Previous v3.1.0 was removed. If no significant changes were detected beyond this, the page now communicates funding-related status and directs users to official status sources.SummaryDifference10%

- Check79 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.2%

Stay in the know with updates to OASIS-HAE: Donidalorsen Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OASIS-HAE: Donidalorsen Safety & Efficacy Clinical Trial page.